|
|
||||||||
Clinical Investigations |
1 Department of Nuclear Medicine, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan
2 Department of Radiation Oncology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan
3 Department of Radiology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan
4 Institute of Nuclear Energy Research, Taoyuan, Taiwan
Distant metastasis is an important issue for nasopharyngeal carcinoma (NPC). The potential value of PET using 18F-FDG has not been well defined. This prospective study investigated the impact of 18F-FDG PET in NPC patients with stage M0 disease. Methods: From April 2001 to June 2003, 140 NPC patients (118 primary and 22 primary recurrent) with stage M0 (negative results from chest radiography, liver sonography, and whole-body bone scanning) underwent 18F-FDG PET to check for distant metastases. Confirmatory MRI or CT was performed if any abnormal 18F-FDG uptake was found at distant sites. The distant lesion was confirmed pathologically, if feasible, and was followed up clinically and with imaging for at least 6 mo. Results: 18F-FDG PET detected 26 true-positive metastatic sites in 18 (12.9%) of the 140 patients, among whom 14 had primary and 4 had recurrent tumors. The patient-based sensitivity and specificity of 18F-FDG PET for distant metastases were 100% and 86.9%, respectively. Mediastinal lymph nodes (n = 8) were the most common sites, followed by lung, liver, and bone (n = 5 each) and by other lymph nodes (n = 3). In patients with primary tumors, advanced nodal status (N23) was a statistically significant variable associated with development of distant metastases (P = 0.044). For recurrent NPC, neither age, sex, initial tumor stage, grade of differentiation, nor nodal stage showed a statistically significant difference between patients with and patients without distant metastases. Conclusion: 18F-FDG PET is valuable in avoiding aggressive locoregional radiotherapy in some NPC patients by the revelation of occult distant metastases, especially in patients with primary disease at a nodal stage of N23.
Key Words: 18F-FDG PET nasopharyngeal carcinoma M0
This article has been cited by other articles:
![]() |
M. Comoretto, L. Balestreri, E. Borsatti, M. Cimitan, G. Franchin, and M. Lise Detection and Restaging of Residual and/or Recurrent Nasopharyngeal Carcinoma after Chemotherapy and Radiation Therapy: Comparison of MR Imaging and FDG PET/CT Radiology, October 1, 2008; 249(1): 203 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
A D KING, B B MA, Y Y YAU, B ZEE, S F LEUNG, J K T WONG, M K M KAM, A T AHUJA, and A T C CHAN The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis Br. J. Radiol., April 1, 2008; 81(964): 291 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamamoto, T. Z. Wong, T. G. Turkington, T. C. Hawk, and R. E. Coleman Head and Neck Cancer: Dedicated FDG PET/CT Protocol for Detection--Phantom and Initial Clinical Studies Radiology, July 1, 2007; 244(1): 263 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-K. Chen, C.-T. Su, K.-H. Chi, R.-H. Cheng, S.-C. Wang, and C.-H. Hsu Utility of 18F-FDG PET/CT Uptake Patterns in Waldeyer's Ring for Differentiating Benign from Malignant Lesions in Lateral Pharyngeal Recess of Nasopharynx J. Nucl. Med., January 1, 2007; 48(1): 8 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-C. Chan, T.-C. Yen, S.-H. Ng, C.-Y. Lin, H.-M. Wang, C.-T. Liao, K.-H. Fan, and J. T.-C. Chang Differential Roles of 18F-FDG PET in Patients with Locoregional Advanced Nasopharyngeal Carcinoma After Primary Curative Therapy: Response Evaluation and Impact on Management J. Nucl. Med., September 1, 2006; 47(9): 1447 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-Y. Liu, J. T. Chang, H.-M. Wang, C.-T. Liao, C.-J. Kang, S.-K. Ng, S.-C. Chan, and T.-C. Yen [18F]Fluorodeoxyglucose Positron Emission Tomography Is More Sensitive Than Skeletal Scintigraphy for Detecting Bone Metastasis in Endemic Nasopharyngeal Carcinoma at Initial Staging J. Clin. Oncol., February 1, 2006; 24(4): 599 - 604. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |